Company / Current Liabilities per Share
Oruka Therapeutics, Inc. Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.78
FY2024
5-year range
$0.04 / $2.20
FY2020-FY2024
Trend
+1657.4%
vs FY2023
Sector context
#125 of 210
Health Care
What the data says
Current Liabilities per Share changed +1657% YoY in FY2024, a notable deviation from the 9-year average annual change of +342%.
Based on SEC 10-K filings.
0.78 in FY2024 with a 5-year CAGR of -8.3%.
Increased from $0.08 to $0.78 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +28.5%
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Sector benchmark
#86 of 210 in Health CareTop 40% of 210This company $0.78 Sector average $15.78
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 1657.4% year-over-year.
- Ranks #125 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.78 | +1657.4% |
| FY2023 | $0.04 | -43.7% |
| FY2022 | $0.08 | -78.6% |
| FY2021 | $0.37 | -83.3% |
| FY2020 | $2.20 | +83.4% |
| FY2019 | $1.20 | +1677.5% |
| FY2018 | $0.07 | -70.5% |
| FY2017 | $0.23 | -13.9% |
| FY2016 | $0.26 | -46.8% |
| FY2015 | $0.50 | +462.5% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026